France: ERES IV takes controlling block in Oncodesign Services and will file takeover bid for remaining shares

Edmond de Rothschild Equity Strategies IV (ERES IV), advised by Elyan Partners, has completed the acquisition of a majority stake in CRO Oncodesign Services first announced earlier in the year. The fund manager has taken 61.58% of Oncodesign Services’ share capital from its main shareholders shareholders, including founder Philippe Genne as well as certain reference…

You must be a HMI Subscriber to view this content.

Subscribe Now »